| 0.924 | 0.003 | 0.924 | Hypolipemic | | |
| 0.786 | 0.004 | 0.786 | Hypoglycemic | | |
| 0.547 | 0.015 | 0.547 | GABA C receptor rho-3 antagonist | | |
| 0.523 | 0.005 | 0.523 | Alpha-N-acetylglucosaminidase inhibitor | | |
| 0.544 | 0.03 | 0.544 | Antibacterial | | |
| 0.508 | 0.004 | 0.508 | GABA C receptor agonist | | |
| 0.534 | 0.041 | 0.534 | Cyclophilin D inhibitor | | |
| 0.463 | 0.006 | 0.463 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.473 | 0.037 | 0.473 | Aldehyde oxidase inhibitor | | |
| 0.449 | 0.052 | 0.449 | 5 Hydroxytryptamine release inhibitor | | |
| 0.402 | 0.008 | 0.402 | Tyrosine 3 hydroxylase inhibitor | | |
| 0.395 | 0.021 | 0.395 | Peroxidase inhibitor | | |
| 0.361 | 0.004 | 0.361 | Ferrochelatase inhibitor | | |
| 0.36 | 0.004 | 0.36 | Triose-phosphate isomerase inhibitor | | |
| 0.388 | 0.037 | 0.388 | Antioxidant | | |
| 0.419 | 0.085 | 0.419 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | | |
| 0.426 | 0.096 | 0.426 | Caspase 9 stimulant | | |
| 0.338 | 0.014 | 0.338 | Lipid peroxidase inhibitor | | |
| 0.372 | 0.052 | 0.372 | 5 Hydroxytryptamine release stimulant | | |
| 0.304 | 0.004 | 0.304 | Carbamoyl phosphate synthetase inhibitor | | |
| 0.309 | 0.009 | 0.309 | Succinate dehydrogenase inhibitor | | |
| 0.281 | 0.006 | 0.281 | Phosphofructokinase-1 inhibitor | | |
| 0.334 | 0.061 | 0.334 | Calcium channel activator | | |
| 0.336 | 0.07 | 0.336 | Cholesterol antagonist | | |
| 0.272 | 0.006 | 0.272 | Glutamate dehydrogenase inhibitor | | |
| 0.269 | 0.005 | 0.269 | Potassium channel large-conductance Ca-activated activator | | |
| 0.265 | 0.004 | 0.265 | Antineoplastic alkaloid | | |
| 0.298 | 0.044 | 0.298 | DNA synthesis inhibitor | | |
| 0.282 | 0.035 | 0.282 | Hepatoprotectant | | |
| 0.238 | 0.008 | 0.238 | Porphobilinogen synthase inhibitor | | |
| 0.232 | 0.003 | 0.232 | Aconitate hydratase inhibitor | | |
| 0.26 | 0.038 | 0.26 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | | |
| 0.33 | 0.109 | 0.33 | Histamine release inhibitor | | |
| 0.278 | 0.059 | 0.278 | Superoxide dismutase inhibitor | | |
| 0.223 | 0.005 | 0.223 | Alcohol oxidase inhibitor | | |
| 0.222 | 0.009 | 0.222 | GABA C receptor antagonist | | |
| 0.223 | 0.012 | 0.223 | Adenylate kinase inhibitor | | |
| 0.302 | 0.096 | 0.302 | Vasodilator, peripheral | | |
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | | |
| 0.215 | 0.014 | 0.215 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | | |
| 0.2 | 0.002 | 0.2 | Squalene synthetase inhibitor | | |
| 0.238 | 0.042 | 0.238 | Nitric-oxide synthase stimulant | | |
| 0.291 | 0.095 | 0.291 | Vasodilator, coronary | | |
| 0.215 | 0.022 | 0.215 | GABA C receptor rho-2 antagonist | | |
| 0.195 | 0.004 | 0.195 | Ca2+-transporting ATPase inhibitor | | |
| 0.259 | 0.072 | 0.259 | Interleukin agonist | | |
| 0.255 | 0.073 | 0.255 | Gastrin inhibitor | | |
| 0.188 | 0.008 | 0.188 | Phenylalanine 4-hydroxylase inhibitor | | |
| 0.217 | 0.039 | 0.217 | 5 Hydroxytryptamine 3E antagonist | | |
| 0.222 | 0.044 | 0.222 | Lipocortins synthesis antagonist | | |
| 0.234 | 0.058 | 0.234 | Anesthetic general | | |
| 0.235 | 0.06 | 0.235 | RNA-directed DNA polymerase inhibitor | | |
| 0.181 | 0.009 | 0.181 | Argininosuccinate synthase inhibitor | | |
| 0.189 | 0.019 | 0.189 | Adenylate cyclase stimulant | | |
| 0.17 | 0.004 | 0.17 | Fumarate hydratase inhibitor | | |
| 0.197 | 0.031 | 0.197 | Cell wall synthesis inhibitor | | |
| 0.186 | 0.02 | 0.186 | UDP-glucose 4-epimerase inhibitor | | |
| 0.176 | 0.013 | 0.176 | GABA C receptor rho-1 antagonist | | |
| 0.17 | 0.01 | 0.17 | Glutamate decarboxylase inhibitor | | |
| 0.184 | 0.027 | 0.184 | Antibacterial (Helicobacter pylori) | | |
| 0.218 | 0.061 | 0.218 | Neurotrophic factor enhancer | | |
| 0.169 | 0.014 | 0.169 | NADH dehydrogenase inhibitor | | |
| 0.25 | 0.096 | 0.25 | Insulysin inhibitor | | |
| 0.161 | 0.008 | 0.161 | Biliverdin reductase inhibitor | | |
| 0.264 | 0.115 | 0.264 | Antithrombotic | | |
| 0.157 | 0.008 | 0.157 | Acyl-CoA dehydrogenase inhibitor | | |
| 0.17 | 0.022 | 0.17 | Catalase inhibitor | | |
| 0.177 | 0.03 | 0.177 | Cystathionine beta-synthase inhibitor | | |
| 0.163 | 0.017 | 0.163 | Histidine decarboxylase inhibitor | | |
| 0.159 | 0.014 | 0.159 | Anabolic | | |
| 0.178 | 0.033 | 0.178 | Cholesterol synthesis inhibitor | | |
| 0.173 | 0.029 | 0.173 | Aminopeptidase B inhibitor | | |
| 0.162 | 0.019 | 0.162 | Creatine kinase inhibitor | | |
| 0.19 | 0.048 | 0.19 | Amylase inhibitor | | |
| 0.15 | 0.013 | 0.15 | Peroxisome proliferator-activated receptor gamma agonist | | |
| 0.139 | 0.003 | 0.139 | Glucose-6-phosphate isomerase inhibitor | | |
| 0.154 | 0.019 | 0.154 | DOPA decarboxylase inhibitor | | |
| 0.131 | 0.001 | 0.131 | HMG CoA reductase inhibitor | | |
| 0.138 | 0.01 | 0.138 | GABA aminotransferase inhibitor | | |
| 0.199 | 0.075 | 0.199 | Insulin sensitizer | | |
| 0.147 | 0.023 | 0.147 | Prolactin inhibitor | | |
| 0.148 | 0.026 | 0.148 | HIV-1 integrase (Overall Integration) inhibitor | | |
| 0.174 | 0.054 | 0.174 | Interferon gamma antagonist | | |
| 0.18 | 0.061 | 0.18 | Phospholipase C inhibitor | | |
| 0.152 | 0.036 | 0.152 | Vanilloid 1 agonist | | |
| 0.132 | 0.016 | 0.132 | Aminopeptidase I inhibitor | | |
| 0.139 | 0.024 | 0.139 | Electrolyte absorption antagonist | | |
| 0.158 | 0.048 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | | |
| 0.114 | 0.006 | 0.114 | Glutamate (mGluR6) antagonist | | |
| 0.122 | 0.015 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | | |
| 0.142 | 0.036 | 0.142 | Photosensitizer | | |
| 0.119 | 0.013 | 0.119 | Glycine receptor agonist | | |
| 0.149 | 0.049 | 0.149 | Cyclooxygenase 3 inhibitor | | |
| 0.135 | 0.034 | 0.135 | Gastric antisecretory | | |
| 0.118 | 0.019 | 0.118 | Glycine receptor antagonist | | |
| 0.11 | 0.011 | 0.11 | GABA B receptor agonist | | |
| 0.136 | 0.041 | 0.136 | Mucolytic | | |
| 0.143 | 0.051 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | | |
| 0.156 | 0.066 | 0.156 | CF transmembrane conductance regulator agonist | | |
| 0.105 | 0.015 | 0.105 | Ornithine carbamoyltransferase inhibitor | | |
| 0.152 | 0.067 | 0.152 | Protein kinase stimulant | | |
| 0.096 | 0.011 | 0.096 | Exportin-1 inhibitor | | |
| 0.105 | 0.02 | 0.105 | Estrogen-related receptor beta agonist | | |
| 0.157 | 0.073 | 0.157 | Melanin inhibitor | | |
| 0.16 | 0.079 | 0.16 | Neurotensin receptor agonist | | |
| 0.131 | 0.05 | 0.131 | Microtubule formation inhibitor | | |
| 0.175 | 0.096 | 0.175 | Psychostimulant | | |
| 0.107 | 0.033 | 0.107 | Glutamate release inhibitor | | |
| 0.095 | 0.021 | 0.095 | Vanilloid 4 agonist | | |
| 0.132 | 0.061 | 0.132 | Cathepsin H inhibitor | | |
| 0.089 | 0.018 | 0.089 | Glutamate (mGluR7) antagonist | | |
| 0.088 | 0.017 | 0.088 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | | |
| 0.1 | 0.032 | 0.1 | Na+ K+ transporting ATPase inhibitor | | |
| 0.088 | 0.021 | 0.088 | Purinergic P2X1 antagonist | | |
| 0.14 | 0.073 | 0.14 | Heat shock protein 70 antagonist | | |
| 0.118 | 0.052 | 0.118 | Acetylcholine release stimulant | | |
| 0.07 | 0.004 | 0.07 | Kainate receptor agonist | | |
| 0.071 | 0.007 | 0.071 | GABA uptake inhibitor | | |
| 0.104 | 0.04 | 0.104 | Ornithine decarboxylase inhibitor | | |
| 0.108 | 0.044 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | | |
| 0.068 | 0.005 | 0.068 | Glutamate (mGluR8) agonist | | |
| 0.098 | 0.037 | 0.098 | Histamine H2 receptor antagonist | | |
| 0.075 | 0.014 | 0.075 | Alpha-mannosidase inhibitor | | |
| 0.143 | 0.082 | 0.143 | Phospholipase A2 inhibitor | | |
| 0.107 | 0.047 | 0.107 | Glutamate (mGluR7) agonist | | |
| 0.071 | 0.013 | 0.071 | Pregnane X receptor antagonist | | |
| 0.22 | 0.162 | 0.22 | Sodium/bile acid cotransporter inhibitor | | |
| 0.144 | 0.086 | 0.144 | Anticoagulant | | |
| 0.128 | 0.07 | 0.128 | Toll-Like receptor 2 antagonist | | |
| 0.07 | 0.012 | 0.07 | Adenylate cyclase 1 inhibitor | | |
| 0.186 | 0.129 | 0.186 | Immunostimulant | | |
| 0.063 | 0.009 | 0.063 | Arginase inhibitor | | |
| 0.11 | 0.059 | 0.11 | Expectorant | | |
| 0.083 | 0.032 | 0.083 | S-adenosyl-L-methionine decarboxylase inhibitor | | |
| 0.081 | 0.033 | 0.081 | Phospholipase D inhibitor | | |
| 0.132 | 0.083 | 0.132 | Mannose-6-phosphate isomerase inhibitor | | |
| 0.078 | 0.03 | 0.078 | NMDA receptor agonist | | |
| 0.076 | 0.03 | 0.076 | Protease 3C (Human rhinovirus) inhibitor | | |
| 0.061 | 0.016 | 0.061 | Mannosidase inhibitor | | |
| 0.086 | 0.042 | 0.086 | Keratolytic | | |
| 0.066 | 0.023 | 0.066 | Ryanodine receptor antagonist | | |
| 0.057 | 0.013 | 0.057 | Dopamine D5 agonist | | |
| 0.114 | 0.071 | 0.114 | Anesthetic local | | |
| 0.054 | 0.013 | 0.054 | Membrane dipeptidase inhibitor | | |
| 0.062 | 0.021 | 0.062 | Lysophosphatidic acid 3 receptor antagonist | | |
| 0.052 | 0.012 | 0.052 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | | |
| 0.059 | 0.02 | 0.059 | Carbonic anhydrase IV inhibitor | | |
| 0.107 | 0.068 | 0.107 | 5 Hydroxytryptamine 3A agonist | | |
| 0.077 | 0.039 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | | |
| 0.113 | 0.075 | 0.113 | Alkylator | | |
| 0.046 | 0.009 | 0.046 | ATP citrate lysase inhibitor | | |
| 0.099 | 0.063 | 0.099 | Carbonic anhydrase III inhibitor | | |
| 0.057 | 0.022 | 0.057 | Aldosterone antagonist | | |
| 0.113 | 0.079 | 0.113 | Aldehyde dehydrogenase inhibitor | | |
| 0.055 | 0.021 | 0.055 | Dopamine beta hydroxylase inhibitor | | |
| 0.07 | 0.036 | 0.07 | NMDA receptor glycine site agonist | | |
| 0.053 | 0.02 | 0.053 | Geranyltranstransferase inhibitor | | |
| 0.052 | 0.019 | 0.052 | Guanylate cyclase inhibitor | | |
| 0.144 | 0.112 | 0.144 | ATPase inhibitor | | |
| 0.085 | 0.055 | 0.085 | D-Ala-D-Ala ligase inhibitor | | |
| 0.034 | 0.004 | 0.034 | Carbonic anhydrase X inhibitor | | |
| 0.034 | 0.004 | 0.034 | Carbonic anhydrase VIII inhibitor | | |
| 0.04 | 0.01 | 0.04 | Glutamate (mGluR3) agonist | | |
| 0.081 | 0.051 | 0.081 | Interferon agonist | | |
| 0.099 | 0.069 | 0.099 | Carbonic anhydrase XV inhibitor | | |
| 0.13 | 0.1 | 0.13 | Pregnane X receptor agonist | | |
| 0.051 | 0.021 | 0.051 | AICAR transformylase inhibitor | | |
| 0.064 | 0.036 | 0.064 | Carbonic anhydrase stimulant | | |
| 0.067 | 0.039 | 0.067 | Interferon inducer | | |
| 0.091 | 0.063 | 0.091 | Alcohol dehydrogenase inhibitor | | |
| 0.034 | 0.006 | 0.034 | Vanilloid 2 agonist | | |
| 0.098 | 0.072 | 0.098 | Falcipain 3 inhibitor | | |
| 0.058 | 0.033 | 0.058 | Leukotriene C antagonist | | |
| 0.034 | 0.009 | 0.034 | Nicotinic acid receptor 2 antagonist | | |
| 0.093 | 0.068 | 0.093 | Sphingomyelinase inhibitor | | |
| 0.104 | 0.08 | 0.104 | TRPA1 agonist | | |
| 0.141 | 0.117 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | | |
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR3) antagonist | | |
| 0.032 | 0.01 | 0.032 | Lysophosphatidic acid receptor 1 agonist | | |
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | | |
| 0.083 | 0.063 | 0.083 | Histamine N-methyltransferase inhibitor | | |
| 0.024 | 0.005 | 0.024 | Telomerase stimulant | | |
| 0.028 | 0.01 | 0.028 | Glutamate (mGluR1a) agonist | | |
| 0.044 | 0.027 | 0.044 | Nerve growth factor antagonist | | |
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | | |
| 0.03 | 0.013 | 0.03 | Hedgehog signaling activator | | |
| 0.031 | 0.015 | 0.031 | Lysine carboxypeptidase inhibitor | | |
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | | |
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | | |
| 0.126 | 0.111 | 0.126 | Growth hormone agonist | | |
| 0.075 | 0.061 | 0.075 | MAP kinase kinase 7 inhibitor | | |
| 0.026 | 0.011 | 0.026 | Prostaglandin F2 alpha agonist | | |
| 0.079 | 0.064 | 0.079 | Calcium antagonist | | |
| 0.02 | 0.005 | 0.02 | Lysophosphatidic acid receptor 3 agonist | | |
| 0.039 | 0.025 | 0.039 | Vanilloid 3 antagonist | | |
| 0.021 | 0.007 | 0.021 | Methylmalonyl-CoA mutase inhibitor | | |
| 0.079 | 0.066 | 0.079 | CC chemokine 5 receptor agonist | | |
| 0.039 | 0.025 | 0.039 | Retinoid X receptor antagonist | | |
| 0.081 | 0.067 | 0.081 | mTOR complex 2 inhibitor | | |
| 0.062 | 0.049 | 0.062 | Leukotriene antagonist | | |
| 0.109 | 0.096 | 0.109 | Sphingosine 1-phosphate receptor 4 antagonist | | |
| 0.017 | 0.005 | 0.017 | Glutamate (mGluR6) agonist | | |
| 0.043 | 0.03 | 0.043 | Histamine H2 receptor agonist | | |
| 0.019 | 0.006 | 0.019 | Thromboxane A2 agonist | | |
| 0.035 | 0.023 | 0.035 | Retinoid X alpha receptor antagonist | | |
| 0.022 | 0.011 | 0.022 | Retinoid X beta receptor antagonist | | |
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | | |
| 0.053 | 0.041 | 0.053 | Thromboxane synthase inhibitor | | |
| 0.046 | 0.035 | 0.046 | Adenosine deaminase inhibitor | | |
| 0.043 | 0.032 | 0.043 | Histamine H1 receptor agonist | | |
| 0.058 | 0.047 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | | |
| 0.083 | 0.072 | 0.083 | Aminoacyl-tRNA synthetase inhibitor | | |
| 0.045 | 0.035 | 0.045 | Thymidylate synthase inhibitor | | |
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | | |
| 0.077 | 0.067 | 0.077 | Glutathione S-transferase inhibitor | | |
| 0.053 | 0.045 | 0.053 | Immunoglobulin Fc receptor antagonist | | |
| 0.034 | 0.025 | 0.034 | Retinoid X alpha receptor agonist | | |
| 0.025 | 0.016 | 0.025 | Glutamate (mGluR1) agonist | | |
| 0.062 | 0.053 | 0.062 | Acetylcholine M5 receptor agonist | | |
| 0.107 | 0.099 | 0.107 | Bone formation stimulant | | |
| 0.038 | 0.03 | 0.038 | Leukotriene C4 antagonist | | |
| 0.03 | 0.022 | 0.03 | Elastase 2B inhibitor | | |
| 0.03 | 0.022 | 0.03 | Elastase 3B inhibitor | | |
| 0.03 | 0.022 | 0.03 | Elastase 3A inhibitor | | |
| 0.047 | 0.04 | 0.047 | Squalene epoxidase inhibitor | | |
| 0.014 | 0.007 | 0.014 | Carbonic anhydrase XI inhibitor | | |
| 0.044 | 0.037 | 0.044 | Peroxisome proliferator-activated receptor alpha agonist | | |
| 0.03 | 0.022 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | | |
| 0.033 | 0.026 | 0.033 | Retinoid X receptor agonist | | |
| 0.09 | 0.083 | 0.09 | Monophenol monooxygenase inhibitor | | |
| 0.052 | 0.045 | 0.052 | Dihydroorotate oxidase inhibitor | | |
| 0.032 | 0.026 | 0.032 | Free fatty acid receptor 1 antagonist | | |
| 0.019 | 0.014 | 0.019 | Antibiotic Anthracycline-like | | |
| 0.016 | 0.011 | 0.016 | Prostacyclin agonist | | |
| 0.024 | 0.02 | 0.024 | Leukotriene D4 antagonist | | |
| 0.037 | 0.032 | 0.037 | Toll-Like receptor 2 agonist | | |
| 0.05 | 0.046 | 0.05 | Heparanase inhibitor | | |
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | | |
| 0.044 | 0.041 | 0.044 | Carnitine palmitoyltransferase 1B inhibitor | | |
| 0.06 | 0.057 | 0.06 | Calcium channel P-type blocker | | |
| 0.029 | 0.026 | 0.029 | Epoxide hydrolase 1 inhibitor | | |
| 0.041 | 0.039 | 0.041 | Antimetabolite | | |
| 0.016 | 0.014 | 0.016 | Vitamin D receptor agonist | | |
| 0.064 | 0.062 | 0.064 | Cathepsin G inhibitor | | |
| 0.014 | 0.013 | 0.014 | Purinergic P2Y1 agonist | | |
| 0.034 | 0.032 | 0.034 | Integrin alpha2 antagonist | | |
| 0.04 | 0.039 | 0.04 | Glutamate (mGluR group III) antagonist | | |
| 0.045 | 0.044 | 0.045 | Cytokine production stimulant | | |
| 0.024 | 0.023 | 0.024 | Uridine phosphorylase inhibitor | | |
| 0.054 | 0.053 | 0.054 | Lipocortins synthesis agonist | | |
| 0.041 | 0.04 | 0.041 | Heme oxygenase inhibitor | | |
| 0.04 | 0.039 | 0.04 | Glutamate (mGluR4) antagonist | | |